- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Cyclophosphamide, Epirubicin, Paclitaxel
Total 7534 results
-
UNC Lineberger Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals; Sai Life SciencesCompletedSolid TumorsUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | Skin MetastasesUnited States
-
Universitätsklinikum Hamburg-EppendorfBARMER; GermanVasc; MDEpiNet Verband Deutschland e.V.Not yet recruitingOutcome, Fatal | Paclitaxel Adverse Reaction
-
European Lung Cancer Working PartyCompletedSmall Cell Lung Carcinoma, Extensive DiseaseBelgium, France, Greece, Spain
-
Medical Research CouncilCompletedGastric CancerUnited Kingdom
-
Institut BergoniéCompleted
-
Damanhour UniversityCompleted
-
China Medical University, ChinaRecruiting
-
Daehwa Pharmaceutical Co., Ltd.CompletedRecurrent or Metastatic Breast CancerUnited States, Czechia
-
Zhejiang Cancer HospitalSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityCompletedEsophageal Squamous Cell CarcinomaChina
-
Provascular GmbHWilliam Cook EuropeCompletedPeripheral Artery DiseaseBelgium, Germany
-
NanOlogy, LLCUS Biotest, Inc.TerminatedUrogenital Neoplasms | Genital Neoplasms, Male | Prostate Cancer | Prostate Adenocarcinoma | Prostatic Neoplasm | Localized Cancer | Prostate Cancer AdenocarcinomaUnited States
-
Samyang Biopharmaceuticals CorporationCompletedNon Small Cell Lung CancerKorea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
The First Affiliated Hospital with Nanjing Medical...UnknownDiffuse Large B Cell LymphomaChina
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
Palleos Healthcare GmbHRoche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...Active, not recruitingTriple-negative Breast CancerGermany
-
Hoffmann-La RocheCompletedBreast CancerUnited States, France, Czechia, Italy, Korea, Republic of, Australia, Belgium, Brazil, Canada, Germany, Guatemala, Hong Kong, Hungary, Panama, Peru, Poland, Spain, Taiwan, United Kingdom, Colombia, Bosnia and Herzegovina, Chile, El... and more
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedAnemia, AplasticUnited States
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditionsUnited States
-
Peking University Cancer Hospital & InstituteRecruitingGastric AdenocarcinomaChina
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
M.D. Anderson Cancer CenterWithdrawnBreast Cancer
-
Medical Research CouncilUnknownEsophageal CancerUnited Kingdom
-
Peking UniversityNot yet recruitingThoracic Esophageal Squamous Cell CarcinomaChina
-
Centre Oscar LambretActive, not recruitingCervical Cancer | Locally Advanced CancerFrance
-
Hemoteq AGCompletedCoronary Artery Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis | Coronary RestenosisGermany, France
-
Philogen S.p.A.Immatics Biotechnologies GmbHTerminatedMerkel Cell CarcinomaGermany, Austria, Denmark, France, Spain, United Kingdom
-
Ohio State University Comprehensive Cancer CenterCelgene Corporation; National Comprehensive Cancer NetworkCompleted
-
Central European Society for Anticancer Drug ResearchUniversity Hospital, Essen; University Hospital, Basel, Switzerland; Assign Data... and other collaboratorsCompletedCarcinoma, Non-Small-Cell LungSwitzerland, Germany
-
Shengjing HospitalRecruiting
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
Muhammad FurqanCelgene CorporationActive, not recruitingSmall Cell Lung Cancer (SCLC)United States
-
Chinese PLA General HospitalZhejiang UniversityRecruitingLymphoma | Solid Tumor, Adult | EphA2 Overexpression | TP53 R273H | TP53 R175H | TP53 R248Q | TP53 R249SChina
-
Roger Williams Medical CenterWithdrawnBreast CancerUnited States
-
Fourth Affiliated Hospital of Guangxi Medical UniversityRecruitingUterine Cervical Neoplasms | Adjuvant Chemotherapy | ChemoradiotherapyChina
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.UnknownNon-Small Cell Lung CancerChina
-
Affiliated Hospital of Qinghai UniversityUnknown
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
National Institute of Oncology, HungaryNot yet recruiting
-
University of Texas Southwestern Medical CenterBerGenBio ASA; Translational Genomics Research Institute; Triligent InternationalTerminatedCancer of PancreasUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
Cancer Institute and Hospital, Chinese Academy...UnknownUterine Cervical CancerChina
-
Canadian Cancer Trials GroupCelgene; Australian and New Zealand Urogenital and Prostate Cancer Trials GroupCompletedUrothelial CancerCanada, Australia
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian... and other conditionsUnited States
-
CelgeneCompletedColorectal NeoplasmsFrance
-
Qilu Hospital of Shandong UniversityWithdrawn
-
CCRF Inc., Beijing, ChinaUnknownPercutaneous Coronary InterventionChina